Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials.

Eichenauer DA, Becker I, Monsef I, Chadwick N, de Sanctis V, Federico M, Fortpied C, Gianni AM, Henry-Amar M, Hoskin P, Johnson P, Luminari S, Bellei M, Pulsoni A, Sydes MR, Valagussa P, Viviani S, Engert A, Franklin J.

Open source

DOI: 10.3324/haematol.2017.167478
Published: 2017-09-14
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2017.167478,
  title = {Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials.},
  author = {Eichenauer DA and  Becker I and  Monsef I and  Chadwick N and  de Sanctis V and  Federico M and  Fortpied C and  Gianni AM and  Henry-Amar M and  Hoskin P and  Johnson P and  Luminari S and  Bellei M and  Pulsoni A and  Sydes MR and  Valagussa P and  Viviani S and  Engert A and  Franklin J.},
  year = {2017},
  journal = {Haematologica},
  doi = {10.3324/haematol.2017.167478},
  url = {https://doi.org/10.3324/haematol.2017.167478}
}

RIS

TY  - JOUR
TI  - Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials.
AU  - Eichenauer DA
AU  -  Becker I
AU  -  Monsef I
AU  -  Chadwick N
AU  -  de Sanctis V
AU  -  Federico M
AU  -  Fortpied C
AU  -  Gianni AM
AU  -  Henry-Amar M
AU  -  Hoskin P
AU  -  Johnson P
AU  -  Luminari S
AU  -  Bellei M
AU  -  Pulsoni A
AU  -  Sydes MR
AU  -  Valagussa P
AU  -  Viviani S
AU  -  Engert A
AU  -  Franklin J.
PY  - 2017
JO  - Haematologica
DO  - 10.3324/haematol.2017.167478
UR  - https://doi.org/10.3324/haematol.2017.167478
ER  -

APA

DA, E., I, B., I, M., N, C., V, D. S., M, F., C, F., AM, G., M, H., P, H., P, J., S, L., M, B., A, P., MR, S., P, V., S, V., A, E., & J., F. (2017). Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials.. Haematologica. https://doi.org/10.3324/haematol.2017.167478

Source records

europe-pmc · retrieved 2026-09-27T13:01:31.248Z
doaj · retrieved 2026-09-27T13:01:31.239Z